Publication | Closed Access
Safety and outcomes of <sup>177</sup>Lu‐DOTATATE for neuroendocrine tumours: experience in New South Wales, Australia
22
Citations
26
References
2019
Year
<sup>177</sup> Lu-DOTATATE is a promising treatment for advanced NET. Superior survival in patients who met selection criteria emphasise the importance of protocol adherence.
| Year | Citations | |
|---|---|---|
Page 1
Page 1